This medication is made by Catalent UK Swindon Zydis Limited for Salix Pharmaceuticals, Inc.
The active ingredient in Metozolv ODT is
metoclopramide, a medication that has several actions in the digestive tract. It causes the esophageal sphincter (which closes the opening from the stomach up to the esophagus) to become more tight while causing the pyloric sphincter (which closes the opening from the stomach out to the intestines) to relax. The drug also increases the muscular
contractions of the stomach and small intestines.
All of these actions work together to help food move through the stomach more quickly, which is why Metozolv ODT is effective for
diabetic gastroparesis treatment. The medication has little or no activity in the
colon.
Metozolv ODT helps with GERD by preventing the stomach contents from refluxing back up the esophagus, since it increases the tightness of the esophageal sphincter.
The drug works to relieve nausea and vomiting by blocking dopamine receptors in the brain, although this is an "off-label" (rather than an approved) use. Dopamine can activate the part of the brain that controls nausea and vomiting, and blocking the receptors helps to alleviate these problems.